Publication | Open Access
Effects of soluble guanylate cyclase stimulator on renal function in ZSF-1 model of diabetic nephropathy
14
Citations
34
References
2022
Year
The sGC stimulator Compound 1 as a monotherapy slowed renal disease progression, and a combination of the sGC stimulator with Enalapril provided greater renal protection in a rodent model of diabetic nephropathy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1